ARCHIVES

Clinical Trial System Inefficient, UPCI Director Tells Senate

This article is from The Cancer Letter archive.

Vol. 28 No. 23 | June 7, 2002

Download PDF Visit The Full Archive

Related Articles

New P01 Guidelines Will Go Into Effect Feb. 1 Not Oct. 1

September 16, 1983

In Brief: Daniel Ihde Named NCI Deputy Director; Roper Is Carter consultant; Another Honor For Forei

February 8, 1991

Blacks, Whites Have Same Contralateral Breast Cancer Risk While On Tamoxifen

December 31, 2004

DCBDC Advisors Table Gl SPORE Over Pancreatic Cancer Research Requirement

March 17, 1995

Ramucirumab Improves Overall Survival, Progression-Free Survival in Phase III Trial

October 26, 2012

FDA Rile Changes Reporting Requirements for Adverse Events

November 18, 1994